Drug Trial Radar · NCT00205777
Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
Last checked: Nov 20, 2026Latest source record: Apr 10, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
7,609
Actual
Start
Dec 2001
Primary completion
Sep 2010
Study completion Sep 2010
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Sep 20, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Single group
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- Female only, from 55 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether bazedoxifene acetate is safe and effective in the treatment of osteoporosis in postmenopausal women.
Conditions
- Osteoporosis
Interventions
Bazedoxifene AcetateDrug
BZA 20mg, daily, oral
PlaceboOther
Placebo, daily, oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With New Vertebral Fractures Through Month 36Time frame: Baseline through Month 36
- Percentage of Participants With New Vertebral Fractures Through Month 60Time frame: Baseline through Month 60
- Percentage of Participants With New Vertebral Fractures Through Month 84Time frame: Baseline through Month 84
Locations
375 sites in 30 countries. Site status is shown where the registry gives one.
Pfizer Investigational Site
Birmingham, Alabama
Pfizer Investigational Site
Birmingham, Alabama
Pfizer Investigational Site
Birmingham, Alabama
Pfizer Investigational Site
Huntsville, Alabama
Pfizer Investigational Site
Mobile, Alabama
Pfizer Investigational Site
Glendale, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Scottsdale, Arizona
Pfizer Investigational Site
Scottsdale, Arizona
Pfizer Investigational Site
Anaheim, California
Pfizer Investigational Site
Berkeley, California
Pfizer Investigational Site
Beverly Hills, California
Pfizer Investigational Site
Fresno, California
Pfizer Investigational Site
Fresno, California
Pfizer Investigational Site
La Jolla, California
Pfizer Investigational Site
Oakland, California
Pfizer Investigational Site
Palm Desert, California
Pfizer Investigational Site
Palm Springs, California
Pfizer Investigational Site
Palm Springs, California
Pfizer Investigational Site
Palm Springs, California
Pfizer Investigational Site
Rancho Mirage, California
Pfizer Investigational Site
Sacramento, California
Pfizer Investigational Site
Sacramento, California
Pfizer Investigational Site
Sacramento, California
Pfizer Investigational Site
San Diego, California
Pfizer Investigational Site
San Diego, California
Pfizer Investigational Site
Upland, California
Pfizer Investigational Site
Whittier, California
Pfizer Investigational Site
Lakewood, Colorado
Pfizer Investigational Site
Longmont, Colorado
Pfizer Investigational Site
Wheat Ridge, Colorado
Pfizer Investigational Site
Bridgeport, Connecticut
Pfizer Investigational Site
Hamden, Connecticut
Showing 40 of 375 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.